Publications of Sandra Nischwitz
All genres
Journal Article (21)
2025
Journal Article
87 (3), pp. 162 - 172 (2025)
Unmasking the Psychological Landscape of Long COVID: A Cluster-analytical Approach. BIOPSYCHOSOCIAL SCIENCE AND MEDICINE 2023
Journal Article
16, 17562864231197309 (2023)
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
Journal Article
16, 17562864231197309 (2023)
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
Journal Article
Neural correlates of transient topographical disorientation: an experimental EEG-MRI case study. JOURNAL OF NEUROLOGY (2023)
2022
Journal Article
13, 915058 (2022)
Combined Fainting and Psychogenic Non-epileptic Seizures as Significant Therapy Hurdles in Blood-Injury-Injection Phobia: A Mini-Review and Case Report. FRONTIERS IN PSYCHIATRY 2020
Journal Article
16 (2), e1007616 (2020)
DeepWAS: Multivariate genotype-phenotype associations by directly integrating regulatory information using deep learning. PLOS COMPUTATIONAL BIOLOGY
Journal Article
161 (4), pp. 787 - 796 (2020)
Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study. PAIN 2019
Journal Article
76 (7), pp. 841 - 849 (2019)
Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis. JAMA NEUROLOGY
Journal Article
266 (2), pp. 386 - 397 (2019)
Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). JOURNAL OF NEUROLOGY 2017
Journal Article
1047, pp. 131 - 140 (2017)
MALDI imaging mass spectrometry Analysis - A new approach for protein mapping in multiple sclerosis brain lesions. JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 2016
Journal Article
2 (6), e1501678 (2016)
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. SCIENCE ADVANCES 2015
Journal Article
39 (8), pp. 601 - 608 (2015)
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array. GENETIC EPIDEMIOLOGY
Journal Article
279, pp. 46 - 49 (2015)
MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 gene. JOURNAL OF NEUROIMMUNOLOGY 2014
Journal Article
130 (1), pp. 46 - 52 (2014)
Interferon-1a reduces increased interleukin-16 levels in multiple sclerosis patients. ACTA NEUROLOGICA SCANDINAVICA 2012
Journal Article
259 (Suppl. 1), p. S13 - S13 (2012)
Methylprednisolone-regulated genes affecting multiple sclerosis pathogenesis. Journal of Neurology 2011
Journal Article
585 (23), pp. 3789 - 3797 (2011)
Risk conferring genes in multiple sclerosis. FEBS Letters
Journal Article
44 (6), p. 300 - 300 (2011)
MALDI imaging - a new tool for mapping multiple sclerosis brain lesions. Pharmacopsychiatry
Journal Article
123 (6), pp. 400 - 406 (2011)
More CLEC16A gene variants associated with multiple sclerosis. Acta Neurologica Scandinavica 2010
Journal Article
227 (1-2), pp. 162 - 166 (2010)
Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. Journal of Neuroimmunology
Journal Article
81 (Suppl. 1), pp. 18 - 19 (2010)
USPIO-gestützte Charakterisierung der weißen Substanz bei MS. Nervenarzt